Congenital antithrombin III (three) deficiency is a genetic disorder that causes the blood to clot more than normal.
Deficiency - antithrombin III - congenital; Antithrombin III deficiency - congenital
Antithrombin III is a protein in the blood that blocks blood clots from forming. It helps the body keep a healthy balance between bleeding and clotting. Congenital antithrombin III deficiency is an inherited disease. It occurs when a person receives one variant copy of the antithrombin III gene from a parent with the disease.
The variant gene leads to a low level of the antithrombin III protein. This low level of antithrombin III can cause blood clots (thrombi) that can block blood flow and damage organs.
People with this condition will often have blood clots at a young age for no reason. They are also likely to have family members who have had a blood clotting problem.
People will usually have symptoms of a blood clot. Blood clots in the arms or legs usually cause swelling, redness, and pain. When a blood clot breaks off from where it formed and travels to another part of the body, it is called a thromboembolism. Symptoms depend on where the blood clot travels to. A common place is the lung, where the clot can cause a cough, shortness of breath, pain while taking deep breaths, chest pain, and even death. Blood clots that travel to the brain can cause a stroke.
A physical exam may show:
Your health care provider can also order a blood test to check if you have a low level of antithrombin III.
A blood clot is treated with blood-thinning medicines (also called anticoagulants). How long you need to take these medicines depends on how serious the blood clot was and other factors. Discuss this with your provider.
More information and support for people with congenital antithrombin III deficiency and their families can be found at:
Most people have a good outcome if they stay on anticoagulant medicines.
Blood clots can cause death. Blood clots in the lungs are very dangerous.
See your provider if you have symptoms of this condition.
Once a person is diagnosed with antithrombin III deficiency, all close family members should be screened for this disorder. Blood-thinning medicines can prevent blood clots from forming and prevent complications from clotting.
Anderson JAM, Weitz JI. Hypercoagulable states. In: Hoffman R, Benz EJ, Silberstein LE, et al, eds. Hematology: Basic Principles and Practice. 8th ed. Philadelphia, PA: Elsevier; 2023:chap 138.
Schafer AI. Thrombotic disorders: hypercoagulable states. In: Goldman L, Cooney KA, eds. Goldman-Cecil Medicine. 27th ed. Philadelphia, PA: Elsevier; 2024:chap 67.